Effect of chronic pain on fentanyl self-administration in mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Wade, Carrie L ^a   Krumenacher, Perry ^a   Kitto, Kelley F ^a   Peterson, Cristina D ^a   Wilcox, George L ^a   Fairbanks, Carolyn A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; SODIUM CHLORIDE; VINCRISTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; EXPERIMENTAL MODEL; FOOD; HYPERALGESIA; INFLAMMATION; MALE; MOTIVATION; MOTOR PERFORMANCE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; OPIATE ADDICTION; PERCEPTIVE THRESHOLD; PERIPHERAL NERVE INJURY; REINFORCEMENT; REWARD; STIMULUS RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; CHRONIC PAIN; FEMALE; FENTANYL; HYPERALGESIA; MALE; MICE; MOTOR ACTIVITY; SELF ADMINISTRATION;

EID: 84896717303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079239     Document Type: Article

References (42)

1. Institute of Medicine (IOM) (2011) Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, D.C.: The National Academies Press.
2. Koob GF, Le Moal M (2008) Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 363: 3113-3123. doi:10.1098/rstb.2008.0094. PubMed: 18653439.
3. Ballantyne JC, LaForge KS (2007) Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129: 235-255. doi:10.1016/j.pain.2007.03. 028. PubMed: 17482363. (Pubitemid 46754581)
4. Bailey JA, Hurley RW, Gold MS (2010) Crossroads of pain and addiction. Pain Med 11: 1803-1818. doi:10.1111/j.1526-4637.2010.00982.x. PubMed: 21040437.
5. Urban MO, Gebhart GF (1999) Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci U S A 96: 7687-7692. doi:10.1073/pnas.96.14.7687. PubMed: 10393881. (Pubitemid 29328341)
6. Kuner R (2010) Central mechanisms of pathological pain. Nat Med 16: 1258-1266. doi:10.1038/nm.2231. PubMed: 20948531.
7. Zieglgänsberger W, Berthele A, Tölle TR (2005) Understanding neuropathic pain. CNS Spectr 10: 298-308. PubMed: 15788957.
8. Koltzenburg M, Wall PD, McMahon SB (1999) Does the right side know what the left is doing? Trends Neurosci 22: 122-127. doi:10.1016/S0166-2236(98)01302- 2. PubMed: 10199637. (Pubitemid 29151805)
9. Woolf CJ (2004) Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 140: 441-451. PubMed: 15023710.
10. Woolf CJ, Doubell TP (1994) The pathophysiology of chronic pain - increased sensitivity to low threshold A beta-fibre inputs. [Review]. 4: 525-534
11. Altier N, Stewart J (1999) The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65: 2269-2287. doi:10.1016/S0024-3205(99)00298-2. PubMed: 10597883. (Pubitemid 29531031)
12. Berhow MT, Hiroi N, Nestler EJ (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16: 4707-4715. PubMed: 8764658. (Pubitemid 26251066)
13. Berhow MT, Russell DS, Terwilliger RZ, Beitner-Johnson D, Self DW et al. (1995) Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68: 969-979. doi:10.1016/0306-4522(95)00207-Y. PubMed: 8545003.
14. Ozaki S, Narita M, Narita M, Ozaki M, Khotib J et al. (2004) Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation. J Neurochem 88: 1389-1397. doi:10.1046/j.1471-4159.2003.02272.x. PubMed: 15009639. (Pubitemid 38366914)
15. Niikura K, Narita M, Narita M, Nakamura A, Okutsu D et al. (2008) Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state. Neurosci Lett 435: 257-262. doi:10.1016/j.neulet.2008.02.059. PubMed: 18359165.
16. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N et al. (2006) Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31: 739-750. doi:10.1038/sj.npp.1300858. PubMed: 16123756.
17. Colpaert FC, Tarayre JP, Alliaga M, Bruins Slot LA, Attal N et al. (2001) Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats. Pain 91: 33-45. doi:10.1016/S0304-3959(00)00413-9. PubMed: 11240076. (Pubitemid 32274173)
18. Lyness WH, Smith FL, Heavner JE, Iacono CU, Garvin RD (1989) Morphine self-administration in the rat during adjuvant-induced arthritis. Life Sci 45: 2217-2224. doi:10.1016/0024-3205(89)90062-3. PubMed: 2601574. (Pubitemid 20003066)
19. Martin TJ, Ewan E (2008) Chronic pain alters drug self-administration: implications for addiction and pain mechanisms. Exp Clin Psychopharmacol 16: 357-366. doi:10.1037/a0013597. PubMed: 18837632.
20. Martin TJ, Kim SA, Buechler NL, Porreca F, Eisenach JC (2007) Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology 106: 312-322. doi:10.1097/00000542-200702000-00020. PubMed: 17264726. (Pubitemid 46185177)
21. Martin TJ, Kim SA, Eisenach JC (2006) Clonidine maintains intrathecal self-administration in rats following spinal nerve ligation. Pain 125: 257-263. doi:10.1016/j.pain.2006.05.027. PubMed: 16806709. (Pubitemid 44708467)
22. Ewan EE, Martin TJ (2011) Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids. Anesthesiology 115: 1271-1280. PubMed: 21946150.
23. Wade CL, Schuster DJ, Domingo KM, Kitto KF, Fairbanks CA (2008) Supraspinally-administered agmatine attenuates the development of oral fentanyl self-administration. Eur J Pharmacol 587: 135-140. doi:10.1016/j.ejphar.2008.04. 007. PubMed: 18495108.
24. Shaham Y, Klein LC, Alvares K, Grunberg NE (1993) Effect of stress on oral fentanyl consumption in rats in an operant self-administration paradigm. Pharmacol Biochem Behav 46: 315-322. doi:10.1016/0091-3057(93)90359-2. PubMed: 8265686.
25. Belknap JK, Crabbe JC, Riggan J, O'Toole LA (1993) Voluntary consumption of morphine in 15 inbred mouse strains. Psychopharmacology 115: 352-358. PubMed: 7871041. (Pubitemid 23278300)
26. Núñez-Olarte JM, Alvarez-Jiménez P (2011) Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain. J Pain Symptom Manag, 42: e6-e8. PubMed: 22048003.
27. Passik SD, Messina J, Golsorkhi A, Xie F (2011) Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manag 41: 116-125. doi:10.1016/j.jpainsymman.2010.03.012. PubMed: 20580202.
28. Woodall KL, Martin TL, McLellan BA (2008) Oral abuse of fentanyl patches (Duragesic): seven case reports. J Forensic Sci 53: 222-225. doi:10.1111/j.1556-4029.2007.00597.x. PubMed: 18279262. (Pubitemid 351239210)
29. Barrueto F Jr., Howland MA, Hoffman RS, Nelson LS (2004) The fentanyl tea bag. Vet Hum Toxicol 46: 30-31. PubMed: 14748415. (Pubitemid 38095886)
30. Fairbanks CA, Nguyen HO, Grocholski BM, Wilcox GL (2000) Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology 93: 765-773. doi:10.1097/00000542-200009000-00026. PubMed: 10969310.
31. Aley KO, Reichling DB, Levine JD (1996) Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience 73: 259-265. doi:10.1016/0306-4522(96)00020-6. PubMed: 8783247. (Pubitemid 26167669)
32. Kim SH, Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355-363. doi:10.1016/0304-3959(92)90041-9. PubMed: 1333581.
33. Ewan EE, Martin TJ (2011) Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain. Anesthesiology 114: 624-632. doi:10.1097/ALN.0b013e31820a4edb. PubMed: 21293250.
34. Gutierrez T, Crystal JD, Zvonok AM, Makriyannis A, Hohmann AG (2011) Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain. Pain 152: 1976-1987. doi:10.1016/j.pain.2011.03.038. PubMed: 21550725.
35. Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F (2003) A new animal model of vincristine-induced nociceptive peripheral neuropathy. Neurotoxicology 24: 797-805. doi:10.1016/S0161-813X(03)00043-3. PubMed: 14637374.
36. Lynch JJ 3rd, Wade CL, Mikusa JP, Decker MW, Honore P (2005) ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model. Eur J Pharmacol 509: 43-48. doi:10.1016/j.ejphar.2004.12.034. PubMed: 15713428. (Pubitemid 40248784)
37. Zhu CZ, Wilson SG, Mikusa JP, Wismer CT, Gauvin DM et al. (2004) Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol 506: 107-118. doi:10.1016/j.ejphar.2004.11.005. PubMed: 15588730. (Pubitemid 39592907)
38. Rahn EJ, Makriyannis A, Hohmann AG (2007) Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Br J Pharmacol 152: 765-777. PubMed: 17572696. (Pubitemid 350041538)
39. Kiguchi N, Maeda T, Kobayashi Y, Kondo T, Ozaki M et al. (2008) The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice. Eur J Pharmacol 592: 87-92. doi:10.1016/j.ejphar.2008.07.008. PubMed: 18652822.
40. Baliki MN, Geha PY, Fields HL, Apkarian AV (2010) Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 66: 149-160. doi:10.1016/j.neuron.2010.03.002. PubMed: 20399736.
41. Tzschentke TM, Schmidt WJ (1995) N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193: 37-40. doi:10.1016/0304-3940(95)11662-G. PubMed: 7566661.
42. Betourne A, Familiades J, Lacassagne L, Halley H, Cazales M et al. (2008) Decreased motivational properties of morphine in mouse models of cancerous- or inflammatory-chronic pain: implication of supraspinal neuropeptide FF(2) receptors. Neuroscience 157: 12-21. doi:10.1016/j.neuroscience.2008.08.045. PubMed: 18804517.